AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment Agreements
25 janv. 2023 08h30 HE
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022
19 déc. 2022 16h15 HE
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
PHILADELPHIA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE
08 déc. 2022 08h19 HE
|
Biomerica, Inc.
IRVINE, Calif., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) received clearance from the Kingdom of Saudi Arabia Food and Drug Administration (KFDA), and the...
Innovations and Growth Opportunities in Novel Diagnostics, Monitoring Technologies and Advanced Medical Devices Including Bionic Pacemakers, Transcranial Stimulation for OCD & Smart Garments
23 nov. 2022 08h28 HE
|
Research and Markets
Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Innovations and Growth Opportunities in Novel Diagnostics, Monitoring Technologies and Advanced Medical Devices" report has been added to ...
PDC Launches Comfort Cushion™ Mammography Pad to Help Breast Health Centers Improve the Patient Experience
25 oct. 2022 09h00 HE
|
PDC
VALENCIA, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- PDC, a global leader of innovative identification and patient safety solutions, announced today the launch of the Comfort Cushion™ Mammography Pad...
Europe Breast Cancer Screening Market Report 2022: Featuring AstraZeneca, Novartis, Sanofi, Pfizer, Bayer, GlaxoSmithKline, Hoffmann-La Roche & Sun Pharmaceutical
24 oct. 2022 04h53 HE
|
Research and Markets
Dublin, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The "Europe Breast Cancer Screening Market, Forecast 2022-2027, Industry Trends, Share, Insight, Growth, Impact of COVID-19, Company Analysis" report has...
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
13 oct. 2022 16h50 HE
|
Biomerica, Inc.
Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD using the InFoods® Technology Notice of Patent Allowance in Japan containing broad claims pertaining to...
Artificial Intelligence in Oncology Market Report 2022: Lower Rates of Diagnostic & Treatment Errors Brought By AI Boosts Adoption
07 oct. 2022 08h43 HE
|
Research and Markets
Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Oncology Market: Distribution by Type of Cancer, Type of End-Users and Key Geographical Regions: Industry Trends and Global...
Worldwide Cancer Profiling Industry to 2027 - Featuring Caris Life Sciences, GenScript, Guardant Health and Sysmex Among Others
30 sept. 2022 04h53 HE
|
Research and Markets
Dublin, Sept. 30, 2022 (GLOBE NEWSWIRE) -- The "Cancer Profiling Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's...
Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease Test Now Available on Amazon and Fulfilled by Amazon
29 sept. 2022 08h19 HE
|
Biomerica, Inc.
Aware® is a simple at-home device to increase sensitivity in breast self-exams. About 80% of breast cancer is detected by women themselves who notice changes in their breast.EZ Detect™ is a simple...